Clinical Trials Browser

Phase 3 × Breast Neoplasms × endostar protein × Clear all

NCT02865304 2016-08-12

The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients

Phase 3 Unknown

Breast Neoplasms